Radiosensitization in human breast carcinoma cells by thymoquinone: role of cell cycle and apoptosis
- 1 October 2011
- journal article
- Published by Wiley in Cell Biology International
- Vol. 35 (10) , 1025-1029
Abstract
TQ (thymoquinone), the bioactive constituent of black seed (Nigella sativa), has been shown to inhibit the growth of various human cancers both in vitro and in vivo. This study reports the radiosensitizing effect of TQ on human breast carcinoma cells (MCF7 and T47D). TQ in combination with single dose of ionizing radiation (2.5 Gy) was found to exert supra‐additive cytotoxic effects on both the carcinomas as measured by cell proliferation and colony‐formation assays. Annexin V binding and FACS analysis revealed the role of enhanced apoptosis and cell cycle modulation in the mechanism of TQ‐mediated radiosensitization, thus supporting TQ as an adjuvant for preclinical testing in cancer chemo‐radiotherapy.Keywords
This publication has 14 references indexed in Scilit:
- Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic CancerCancer Research, 2009
- Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathwaysMolecular Cancer Therapeutics, 2008
- Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancerCancer Treatment Reviews, 2008
- DNA Damage Responses: Mechanisms and Roles in Human DiseaseMolecular Cancer Research, 2008
- Increased cytotoxicity by the combination of radiation and diospyrin diethylether in fibrosarcoma in culture and in tumorInternational Journal of Radiation Biology, 2008
- Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer modelsJournal of Cellular and Molecular Medicine, 2007
- Thymoquinone: A promising anti-cancer drug from natural sourcesThe International Journal of Biochemistry & Cell Biology, 2006
- Radioresistance in carcinoma of the breastThe Breast, 2004
- Curcumin downregulates cell survival mechanisms in human prostate cancer cell linesOncogene, 2001
- Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activityCanadian Journal of Physiology and Pharmacology, 1997